5G1: Phase II

In a double-blind U.S. Phase II trial of 5G1.1 in 209 patients with mild to moderate

Read the full 162 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE